NCT03551821View on ClinicalTrials.gov

Open Label Study of ATI-50002 Topical Solution Administered to Adult Subjects With Eyebrow Loss Due to Alopecia Areata

PHASE2CompletedINTERVENTIONAL
Enrollment

1

Participants

Timeline

Start Date

April 11, 2018

Primary Completion Date

November 6, 2018

Study Completion Date

November 6, 2018

Conditions
Alopecia AreataAlopecia TotalisAlopecia Universalis
Interventions
DRUG

ATI-50002

Topical Solution

Trial Locations (1)

33472

Aclaris Investigator Site, Boynton Beach

Sponsors
All Listed Sponsors
lead

Aclaris Therapeutics, Inc.

INDUSTRY